- Home
- XRTX vs AKAN Comparison
XRTX vs AKAN Comparison
Compare XRTX & AKAN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- XRTX
- AKAN
- Stock Information
- Founded
- XRTX 2011
- AKAN 2021
- Country
- XRTX Canada
- AKAN Canada
- Employees
- XRTX N/A
- AKAN N/A
- Industry
- XRTX Pharmaceuticals and Biotechnology
- AKAN Medicinal Chemicals and Botanical Products
- Sector
- XRTX Health Care
- AKAN Health Care
- Exchange
- XRTX Nasdaq
- AKAN Nasdaq
- Market Cap
- XRTX 3.4M
- AKAN 2.9M
- IPO Year
- XRTX N/A
- AKAN 2022
- Fundamental
- Price
- XRTX $0.90
- AKAN $1.33
- Analyst Decision
- XRTX
- AKAN
- Analyst Count
- XRTX 0
- AKAN 0
- Target Price
- XRTX N/A
- AKAN N/A
- AVG Volume (30 Days)
- XRTX 88.1K
- AKAN 560.0K
- Earning Date
- XRTX 08-18-2025
- AKAN 08-19-2025
- Dividend Yield
- XRTX N/A
- AKAN N/A
- EPS Growth
- XRTX N/A
- AKAN N/A
- EPS
- XRTX N/A
- AKAN N/A
- Revenue
- XRTX N/A
- AKAN $836,664.00
- Revenue This Year
- XRTX N/A
- AKAN N/A
- Revenue Next Year
- XRTX N/A
- AKAN N/A
- P/E Ratio
- XRTX N/A
- AKAN N/A
- Revenue Growth
- XRTX N/A
- AKAN 97.47
- 52 Week Low
- XRTX $0.66
- AKAN $0.93
- 52 Week High
- XRTX $2.98
- AKAN $3.20
- Technical
- Relative Strength Index (RSI)
- XRTX 57.65
- AKAN 54.26
- Support Level
- XRTX $0.73
- AKAN $1.00
- Resistance Level
- XRTX $0.82
- AKAN $1.46
- Average True Range (ATR)
- XRTX 0.07
- AKAN 0.18
- MACD
- XRTX 0.01
- AKAN 0.02
- Stochastic Oscillator
- XRTX 90.96
- AKAN 45.83
About XRTX XORTX Therapeutics Inc.
XORTX Therapeutics Inc is a clinical-stage biotechnology company focused on identifying, developing, and potentially commercializing therapies to treat progressive kidney disease modulated by aberrant purine and uric acid metabolism and uric acid metabolism in orphan (rare) disease indications such as ADPKD and T2DN, as well as AKI associated with respiratory virus infection. Its focus is on developing three therapeutic products to slow or reverse the progression of chronic kidney disease, address the immediate need of individuals facing AKI associated with respiratory virus infection, and identify other opportunities where existing and new intellectual property can be leveraged to address health issues.
About AKAN Akanda Corp.
Akanda Corp is a cannabis cultivation, manufacturing, and distribution company. The company has three reportable segments: Cultivation, Distribution, and Corporate. A majority of its revenue is generated from the Distribution segment, which relates to the distribution of medical cannabis products, including cannabis oil and cannabis flower for medical use in the United Kingdom.